Journal of Medical Screening

Papers
(The TQCC of Journal of Medical Screening is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada126
Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer50
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States34
Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis24
COVID-19 disruption to cervical cancer screening in England24
Google search volume trends for cancer screening terms during the COVID-19 pandemic22
Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: A census of over seven million newborns between 2016 and 201720
Folic acid and neural tube defects: Discovery, debate and the need for policy change19
Cervical screening attendance and cervical cancer risk among women who have sex with women19
The randomized trial of mammography screening that was not—A cautionary tale18
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographers17
Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England14
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost–utility analysis13
Retrospective analysis of the effect on interval cancer rate of adding an artificial intelligence algorithm to the reading process for two-dimensional full-field digital mammography13
Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs12
A novel mobile phone application for infant stool color recognition: An easy and effective tool to identify acholic stools in newborns12
Modeling costs and benefits of the organized colorectal cancer screening programme and its potential future improvements in Hungary10
Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia10
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study10
Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study9
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing9
Systematic review and meta-analysis of colon capsule endoscopy accuracy for colorectal cancer screening. An alternative during the Covid-19 pandemic?9
All-cause mortality as the primary endpoint for the GRAIL/National Health Service England multi-cancer screening trial9
Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme9
Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study9
Women screened for breast cancer are dying from lung cancer: An opportunity to improve lung cancer screening in a mammography population9
The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia9
Cost-effectiveness analysis of lung cancer screening with low-dose computed tomography in an Iranian high-risk population8
Retrospective comparison between single reading plus an artificial intelligence algorithm and two-view digital tomosynthesis with double reading in breast screening8
Screening participants’ attitudes to the introduction of artificial intelligence in breast screening8
Test accuracy of artificial intelligence-based grading of fundus images in diabetic retinopathy screening: A systematic review8
The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis7
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review7
Impact of the COVID-19 pandemic on colorectal cancer screening in New York City7
Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies6
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 20206
Benefits of digital breast tomosynthesis: A lesion-level analysis6
Major failings of trial procedures and quality of screening fatally compromise the results of the Canadian National Breast Screening Studies5
Breast cancer mortality after eight years of an improved screening program using digital breast tomosynthesis5
Did the use of open invitations in place of timed appointment invitations reduce the uptake of breast screening in the London region during the COVID-19 recovery?5
Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey5
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India5
Beneficial effect of repeated participation in breast cancer screening upon survival4
Quality measures of a multicentre universal newborn hearing screening program in Malaysia4
Door-to-door hepatitis C screening in Georgia: An innovative model to increase testing and linkage to care4
The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area4
Trends in colorectal cancer screening in the United States, 2012 to 20204
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study4
The impact of cumulative colorectal cancer screening delays: A simulation study4
HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial4
0.029463052749634